Inherited disorders of cobalamin metabolism disrupt nucleocytoplasmic transport of mRNA through impaired methylation/phosphorylation of ELAVL1/HuR. Issue 15 (17th July 2018)

• Record Type: Journal Article
• Authors: Battaglia-Hsu, Shyue-Fang; Ghemrawi, Rose; Coelho, David; Dreumont, Natacha; Mosca, Pauline; Hergalant, Sébastien; Gauchotte, Guillaume; Sequeira, Jeffrey M; Ndiongue, Mariam; Houlgatte, Rémi; Alberto, Jean-Marc; Umoret, Remy; Robert, Aurélie; Paoli, Justine; Jung, Martin; Quadros, Edward V; Guéant, Jean-Louis
• Is Part Of: Nucleic acids research. Volume 46:Issue 15(2018)
• Page Start: 7844
• Page End: 7857
• Publication Date: 2018-07-17
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gky634
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: The molecular mechanisms that underlie the neurological manifestations of patients with inherited diseases of vitamin B12 (cobalamin) metabolism remain to date obscure. We observed transcriptomic changes of genes involved in RNA metabolism and endoplasmic reticulum stress in a neuronal cell model with impaired cobalamin metabolism. These changes were related to the subcellular mislocalization of several RNA binding proteins, including the ELAVL1/HuR protein implicated in neuronal stress, in this cell model and in patient fibroblasts with inborn errors of cobalamin metabolism and Cd320 knockout mice. The decreased interaction of ELAVL1/HuR with the CRM1/exportin protein of the nuclear pore complex and its subsequent mislocalization resulted from hypomethylation at R-217 produced by decreased S-adenosylmethionine and protein methyl transferase CARM1 and dephosphorylation at S221 by increased protein phosphatase PP2A. The mislocalization of ELAVL1/HuR triggered the decreased expression of SIRT1 deacetylase and genes involved in brain development, neuroplasticity, myelin formation, and brain aging. The mislocalization was reversible upon treatment with siPpp2ca, cobalamin, S-adenosylmethionine, or PP2A inhibitor okadaic acid. In conclusion, our data highlight the key role of the disruption of ELAVL1/HuR nuclear export, with genomic changes consistent with the effects of inborn errors of Cbl metabolisms on brain development, neuroplasticity and myelin formation.